amisulpridum - rizultati

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

apo-amisulpride

amisulpride -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

amisulpride sandoz 400 amisulpride 400 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

amisulpride sandoz 200 amisulpride 200 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

amisulpride sandoz 100 amisulpride 100 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

amisulpride 400 winthrop amisulpride 400 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; peg-40 stearate; lactose monohydrate; titanium dioxide; hypromellose; microcrystalline cellulose - the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.